Periodic Reporting for period 1 - CASI (AN INTEGRATED AUTOMATED ECG DIAGNOSTICS PLATFORM TO IMPROVE CARDIAC SAFETY IN CLINICAL DRUG TRIALS)

The purpose of the CaSI phase 1 action was to assess the commercial and technical feasibility of a proposed new solution for cardiac safety in clinical drug trials. Cardiac safety in clinical trials is a mandatory requirement and the market has grown to be worth over €1Bn...